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SUMMARY Lyme borreliosis is very important for dermato- 
venereologists because of its skin manifestations that include 
erythema chronicum migrans, lymphadenosis benigna cutis, and 
acrodermatitis chronica atrophicans. In Croatia, the spirochete 
Borrelia burgodorferi was first isolated in 1991 at University De-
partment of Dermatology and Venereology, Zagreb University 
Hospital Center. In October 2003, the Laboratory of Clinical Immu-
nology, Immunofluorescence and Serodiagnosis was appointed 
Reference Center  of the Ministry of Health and Social Welfare 
of the Republic of Croatia for the Diagnosis of Syphilis and Lyme 
Disease. Results of immunofluorescence diagnosis of Lyme dis-
ease are reported and areas in Croatia endemic for Lyme bor-
reliosis are presented.
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Historical Background
 Lyme disease (LD) is a tick-borne infection 
caused by the spirochete Borrelia (B.) burgdorferi 
sensu lato. LD originated from the USA and there-
fore the isolated borreliae most probably belong 
to the B. burgdorferi sensu stricto strain. Recent 
findings have revealed that specific genotypic 
subtypes of B. burgdorferi sensu stricto have dif-
ferent propensities for hematogenous dissemina-
tion in early LD, suggesting that these differences 
may influence the pathogenesis of the disease. 
The pathogenic mechanism of LD, particularly of 
the pathognomonic clinical sign of LD, is erythema 
migrans (EM). In several days to weeks or even 
months, B. burgdorferi may disseminate hematog-
enously or lymphogenously from skin to various 
organs leading to clinical manifestations of LD of 
the early disseminated and/or late infection (2). LD 
presents as early localized Lyme borreliosis (LB), 
early disseminated LB, and late chronic LB. Late-
stage disease occurs rather frequently in patients 
who have received treatment at an early stage 
of LB (localized or disseminated) (1). Many fac-
tors seem to influence the presence of spirochete 
antigens in infected persons and the introduction 
of immune effects (e.g., increased number of an-
tigens in complexes, surviving of spirochetes at 
the immunologically privileged sites, and main-
taining of immunologic antigens). Determination 
of soluble (s) CD4, CD8 and CD25 antigens in pa-
tient sera may be useful in the evaluation of the 
state of immune activation, and might contribute 
to better assessment of the antibiotic treatment ef-
ficacy (1). Increased initial concentrations of sCD8 
and sCD25 indicate the activation of CD8 and CD25 
lymphocytes and their role in the immunopatho-
genesis of LD. Elevated levels of CD8, before and 
after treatment suggest a significant involvement 
of CD8 lymphocytes, indicating the role of long-
lasting cellular response in early disseminated LB. 
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 In Europe, B. burgdorferi sensu lato determined 
in the blood of patients with typical EM was low; 
the predominantly isolated strain was B. afzelii (2). 
Slovenia is an endemic country for LB with a vast 
majority of LB patients registered with EM and pre-
dominance of B. afzelii isolated from blood. In the 
majority of EM patients, spirochetemia was clini-
cally silent, had no adverse prognostic significance 
upon therapeutic approach, and proceeded with-
out clinical signs of disseminated borrelia infection 
(2). The course and outcome of EM patients was 
assessed according to clinical evaluation, labo-
ratory serology, cultivation of Borrelia from skin 
specimens, and cultivation of Borrelia from blood. 
Literature search has revealed the frequency of 
isolation of spirochetes from the blood of patients 
with EM to be low, ranging from 2.5% to 5.5% in 
the majority of reports; however, in some reports it 
was as high as 21% (3-8). Clinical-epidemiologic 
studies support the view that there are clinically 
characteristics of the pathogen which is capable 
to survive in compartments for a prolonged pe-
riod of time. Research on improved methods to 
diagnose and treat later stages of LD is needed. 
 
 Croatian Experience in Lyme Disease 
 Research
 In Croatia, the spirochete B. burgdorferi was 
first isolated in 1991 at University Department of 
Dermatology and Venereology, Zagreb University 
Hospital Center, from the skin of a patient with ery-
thema chronicum migrans (ECM), and was desig-
nated as P1 Zagreb. As an early skin manifesta-
tion of LB, it was first described by Forenbacher in 
1940, followed by Mohar in 1982, Maretić et al. in 
1989, Curl in 1991, Kansky in 1992, and Bolanča-
Bumber in 1997 (11). In 1998, Šitum reported 
on clinical and laboratory analysis performed in 
a group of 148 selected subjects (20 from a risk 
population of forestry workers from a nonendemic 
area, 82 from a risk population of forestry work-
ers from an LB endemic area, and 46 LB affected 
subjects) (11,12). LB is a multisystem disease 
caused by the spirochete B. burgdorferi. Small ro-
dents, hedgehog, wood mouse, field mouse and 
doormouse, birds, deer and vole are natural B. 
burgdorferi reservoirs, whereas domestic animals 
(cattle, sheep, horse, dog, etc.) play an important 
role in the spread of the disease in inhabited areas 
(11,12). 
 From B. burgdorferi designated as P1 Zagreb, 
electrophoretic analysis of B. burgdorferi protein 
content revealed six major proteins of different 
molecular mass (OspA, OspB, OspC, p41, p60 
and p100) (11).
 In northwest Croatia, an endemic area for Lyme 
borreliosis, four genomic B. burgdorferi sensu lato 
groups were identified in the Ixodes ricinus ticks: 
B. afzelii, B. garnii, B. valaisiana  (group VSS116), 
and B. burgdorferi sensu stricto (11).
 
Table 1. Frequency of early manifestations of 
Lyme disease at Dermatology and Venereology 
Health Services in central, north and east Croatia 
(1985-1994)
Dermatologic Service ECM Tick bites
Koprivnica 131 25
Karlovac 171 66
Čakovec (1991-1994)*  98 -





*Data obtained from the Polyclinic for Infectious Dis-
eases (1991-1994) and Dermatovenereology Service 
Table 2. Frequency of Lyme borreliosis infection 
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relevant differences regarding tissue tropism and 
perhaps virulence between B. burgdorferi sensu 
stricto and other Borrelia species such as B. afzelii 
and B. garinii (9). The cutaneous manifestation of 
infection with Borrelia species, EM, may be asso-
ciated with systemic signs of the disease such as 
fever and malaise. Several studies have shown 
that systemic dissemination of spirochetes occurs 
during this phase of infection (1.2% in ref. 2); 25% 
of cases in Wormser et al. (10). Patients with dis-
seminated LD have persistently elevated levels 
of (s) CD8 and CD25 receptors, which indicate the 
presence of persistently activated CD8 lympho-
cytes (1). Components of the cellular response 
such as T lymphocytes react to distinct spirochete 
proteins such as outer surface lipoprotein Osp A 
(9). Likewise, we need to learn more about the 
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 In her study Šitum included specific endemic 
areas for Lyme disease in Croatia and the results 
confirmed B. afzelii to be the main causative agent 
of ECM in the study group from the area (12). 
 As no similar studies have been conducted in 
other parts of Croatia, there is a dilemma whether 
B. afzelii is the causative agent of ECM, the most 
common manifestation of Lyme disease, in other 
parts of Croatia. There is the need of investigating 
other clinical types of Lyme disease such as Lyme 
arthritis and neuroborreliosis in order to determine 
whether other B. burgdorferi genospecies are also 
included in the etiology of extracutaneous types of 
Lyme disease (11).
 Over the last 14 years, LD has grown into a 
public health problem, especially in the USA and 
Central Europe as well as in Croatia. Besides the 
skin, joints, heart and central nervous system 
can be involved. LD is very important for derma-
tologists for the three diseases described: ECM, 
lymphadenosis benigna cutis (LBC) and acroder-
matitis chronica atrophicans (ACA).
 From 1988 till 1990, 907 cases of ECM were 
recorded in central and north Croatia, the areas 
considered endemic for LB. In 1995, 216 cases of 
ECM were recorded in Osijek (east Croatia) (Table 
1) (13). Data on LB prevalence in Croatia during 
the 1992-1998 period are shown in Table 2 (14). 
 
 Immunofluorescence Diagnosis of B.  
 burgdorferi Antibodies
 At University Department of Dermatology and 
Venereology, Zagreb University Hospital Center, 
the Laboratory of Serodiagnosis and Immunofluo-
rescence Diagnosis has now for years been per-
forming immunofluorescence (IF) diagnosis of B. 
burgdoferi, with special reference to IgG and IgM 
titer in positive cases. Positive IF B. burgdoferi 
findings prevailed with IgG antibodies have been 
progressively seen since 1996. Results recorded 
during the 1990-2004 period are shown in Figures 
1 and 2. Since the appointment of the Reference 
Center for the Diagnosis of Lyme Disease of the 
Ministry of Health and Welfare of the Republic of 
Croatia in 2003, the diagnosis, prevention and 
treatment of LD have become the most important 
tasks of the Center. Table 3 presents positive IF 
findings recorded during the last two years. IgG 
and IgM positive findings were similar during the 
last two years because target sera were referred 





Figure 2. Distribution of IgG and IgM Borrelia burgdorferi antibodies in 2967 positive sera during 
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Figure 2. Distribution of IgG and IgM Borrelia 
burgdorferi antibodies in 2967 positive sera during 
15 years at Laboratory of Lyme Disease Serodi-
agnosis 
IIF for Borrelia burgdorferi
   2003 2004
Total   616 692
Negative  251 240
Positive   365 452
  
Positive  
IgM    IgG titer   
            IgM  1:64 64 45
                    1:128 32 33
                    1:256 12 10
                    1:512 16 4
            IgG  1:64 47 56
                    1:128 96 136
                    1:256 110 143
                    1:512 97 99
Table 3. Current results of indirect immunofluores-
cence (IIF) testing for Borrelia burgdorferi at Ref-
erence Center for Lyme Disease of the Ministry of 
Health and Welfare of the Republic of Croatia 
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Figure 1. Indirect immunofluorescence test results in 9090 patient sera during 15 years at 
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Figure 1. Indirect immunofluorescence test results 
in 9090 patient sera during 15 years at Laboratory 
of Lyme Disease Serodiagnosis 
 In Croatia, the geographical and climate 
characteristics are favorable for the life cycle 
and spread of the Ixodes ticks (i.e. woodlands 
with humid climate). The central, north and 
east parts of Croatia are endemic areas for LB. 
 In Croatia, diagnostic workup for LD is per-
formed by dermatovenereologists and infectolo-
gists. At University Department of Dermatology 
and Venereology, Zagreb University School of 
Medicine, laboratory diagnosis of antibodies to 
B. burgdoferi using indirect immunofluorescence 
has been done since 1988, and B. burgdoferi cul-
tivation since 1991, whereas ELISA testing is per-
formed at Dr. Fran Mihaljević University Hospital 
for Infectious Diseases in Zagreb, with close col-
laboration between the two institutions.
 The Reference Center  of the Ministry of Health 
and Welfare of the Republic of Croatia for the Di-
agnosis of Lyme Disease has an important role in 
accurate diagnosis of LB and treatment of ECM 
as well as in the prevention of possible late LB 
manifestation and proper education of general 
practitioners. Tight collaboration with dermatove-
nereologists all over Croatia is necessary to pro-
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